157 filings
Page 3 of 8
8-K
ax4wjvid033pd2mk
19 Feb 21
Departure of Directors or Certain Officers
4:30pm
8-K
5kw2phdfs2a98eg7l
4 Feb 21
Departure of Directors or Certain Officers
4:31pm
8-K
dixjhk m2y5c
25 Jan 21
Biostage Strengthens Board of Directors with Appointment of Herman Sanchez
8:05am
8-K
vdy23u2zkiys8
31 Dec 20
Other Events
12:00am
8-K
8bh1yaqnrtb8
13 Nov 20
Biostage Reports Third Quarter 2020 Financial Results
4:15pm
8-K
eip38i5x 2xem21zr
30 Oct 20
Departure of Directors or Certain Officers
8:00am
8-K
ooahtfln 4gs8
2 Oct 20
Unregistered Sales of Equity Securities
12:00am
8-K
eq90p1l0r7fvno
8 Sep 20
Departure of Directors or Certain Officers
4:15pm
8-K
ejr9um9x
31 Aug 20
Departure of Directors or Certain Officers
4:19pm
8-K
4948m7h
20 Aug 20
Entry into a Material Definitive Agreement
4:25pm
8-K
tjxqxnc
13 Aug 20
Biostage Reports Second Quarter 2020 Financial Results
4:22pm
8-K
2bbg34 wb
1 Jul 20
Other Events
4:01pm
8-K
6ypp nbivmo
22 Jun 20
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
yi03i3f
14 May 20
Biostage Reports First Quarter 2020 Financial Results
4:10pm
8-K
7squj
5 May 20
Entry into a Material Definitive Agreement
4:05pm
8-K
1c5vc3m
30 Apr 20
Unregistered Sales of Equity Securities
4:06pm
8-K
vdu0e9gkpza
27 Mar 20
Biostage Reports 2019 Financial Results
4:11pm
8-K
zzn8mkod2o4aryk ph
24 Mar 20
Departure of Directors or Certain Officers
4:45pm
8-K
pd4vg3ads66v088sz
20 Mar 20
Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan™ Esophageal Implant
7:05am
8-K
7wy8v
20 Feb 20
Biostage Submitted Official Response to FDA for Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal Implant
4:05pm